Chemical formula: C₂₁H₂₃ClFN₃O Molecular mass: 387.878 g/mol PubChem compound: 3393
Flurazepam is a psychotropic substance from the class of 1,4-benzodiazepines. Flurazepam binds to specific benzodiazepine receptors located on GABA-ergic neurones and potentiates the inhibitory actions of GABA-ergic neurones in the nervous system. Flurazepam is used as a short-term treatment of insomnia.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| N05CD01 | Flurazepam | N Nervous system → N05 Psycholeptics → N05C Hypnotics and sedatives → N05CD Benzodiazepine derivatives |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| DALMANE Capsule | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
Flurazepam is an active ingredient of these brands:
Brazil (BR)
Croatia (HR)
Germany (DE)
Ireland (IE)
Japan (JP)
Malta (MT)
South Africa (ZA)
Spain (ES)
United Kingdom (UK)
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
